Study groups | n = 80 (%) | HBD-3 levels Mean ± SD | t-test (p-value)a |
---|---|---|---|
ECC | |||
Cases (with ECC) | 40 (50) | 8.87 ± 4.30 | 2.064 (0.042)a |
Controls (without ECC) | 40(50) | 7.23 ± 2.57 | |
Anemia | |||
With anemia | 40(50) | 7.15 ± 2.82 | − 2.482(0.015)a |
Without anemia | 40(50) | 9.02 ± 3.96 | |
Age groups | |||
48–59 Months | 22(27.5) | 8.31 ± 3.67 | 0.730b |
60–71 Months | 58(72.5) | 7.95 ± 3.62 | |
Gender | |||
Males | 33(41.25) | 7.54 ± 2.67 | 0.292a |
Females | 47(58.75) | 8.41 ± 4.14 |